These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 7682246)
1. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice. Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863 [TBL] [Abstract][Full Text] [Related]
3. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614 [TBL] [Abstract][Full Text] [Related]
4. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. Giese T; Davidson WF J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297 [TBL] [Abstract][Full Text] [Related]
5. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities. Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108 [TBL] [Abstract][Full Text] [Related]
6. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice. Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621 [TBL] [Abstract][Full Text] [Related]
7. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. Giese T; Davidson WF J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337 [TBL] [Abstract][Full Text] [Related]
8. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. Giese T; Allison JP; Davidson WF J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618 [TBL] [Abstract][Full Text] [Related]
9. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain. Yui K; Bhandoola A; Radic MZ; Komori S; Katsumata M; Greene MI Eur J Immunol; 1992 Jul; 22(7):1693-700. PubMed ID: 1385574 [TBL] [Abstract][Full Text] [Related]
11. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. Giese T; Davidson WF J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404 [TBL] [Abstract][Full Text] [Related]
12. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. Zhou T; Bluethmann H; Eldridge J; Brockhaus M; Berry K; Mountz JD J Immunol; 1991 Jul; 147(2):466-74. PubMed ID: 1830064 [TBL] [Abstract][Full Text] [Related]
13. Selection of the T cell receptor repertoire in Lpr mice. Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785 [TBL] [Abstract][Full Text] [Related]
14. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Benihoud K; Bonardelle D; Bobé P; Kiger N Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912 [TBL] [Abstract][Full Text] [Related]
15. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals. Mixter PF; Russell JQ; Morrissette GJ; Charland C; Aleman-Hoey D; Budd RC J Immunol; 1999 May; 162(10):5747-56. PubMed ID: 10229807 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice. Mountz JD; Smith TM; Toth KS J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237 [TBL] [Abstract][Full Text] [Related]
17. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion. Balomenos D; Rumold R; Theofilopoulos AN J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315 [TBL] [Abstract][Full Text] [Related]
18. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545 [TBL] [Abstract][Full Text] [Related]
19. Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts. Iiai T; Kimura M; Kawachi Y; Hirokawa K; Watanabe H; Hatakeyama K; Abo T Immunology; 1995 Apr; 84(4):601-8. PubMed ID: 7790034 [TBL] [Abstract][Full Text] [Related]
20. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice. Mountz JD; Zhou T; Eldridge J; Berry K; Blüthmann H J Exp Med; 1990 Dec; 172(6):1805-17. PubMed ID: 1701823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]